|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/24/21 Aethlon Medical Inc. 10-K 3/31/21 70:4.8M GlobalOne Filings Inc/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 651K
2: EX-10.12 Non-Employee Director Compensation Policy HTML 26K
3: EX-23.1 Consent of Independent Registered Public HTML 18K
Accounting Firm
4: EX-31.1 Certification Pursuant to Rule HTML 22K
13A-14(A)/15D-14(A), as Adopted
5: EX-31.2 Certification Pursuant to Rule HTML 22K
13A-14(A)/15D-14(A), as Adopted
6: EX-32.1 Certification Pursuant to 18 U.S.C. Section 1350 HTML 19K
7: EX-32.2 Certification Pursuant to 18 U.S.C. Section 1350 HTML 19K
14: R1 Document and Entity Information HTML 57K
15: R2 Consolidated Balance Sheets HTML 129K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 27K
17: R4 Consolidated Statements of Operations HTML 81K
18: R5 Consolidated Statements of Equity (Unaudited) HTML 84K
19: R6 Consolidated Statements of Cash Flows HTML 108K
20: R7 1. Organization, Liquidity and Summary of HTML 90K
Significant Accounting Policies
21: R8 2. Property and Equipment HTML 27K
22: R9 3. Patents, Net HTML 28K
23: R10 4. Convertible Notes Payable HTML 24K
24: R11 5. Equity Transactions HTML 151K
25: R12 6. Related Party Transactions HTML 27K
26: R13 7. Other Current Liabilities HTML 25K
27: R14 8. Income Taxes HTML 49K
28: R15 9. Segments HTML 65K
29: R16 10. Subsequent Events HTML 29K
30: R17 11. Commitments and Contingencies HTML 33K
31: R18 1. Organization, Liquidity and Summary of HTML 139K
Significant Accounting Policies (Policies)
32: R19 1. Organization, Liquidity and Summary of HTML 30K
Significant Accounting Policies (Tables)
33: R20 2. Property and Equipment (Tables) HTML 25K
34: R21 3. Patents (Tables) HTML 27K
35: R22 4. Convertible Notes Payable (Tables) HTML 23K
36: R23 5. Equity Transactions (Tables) HTML 113K
37: R24 6. Related Party Transactions (Tables) HTML 25K
38: R25 7. Other Current Liabilities (Tables) HTML 25K
39: R26 8. Income Taxes (Tables) HTML 45K
40: R27 9. Segments (Tables) HTML 60K
41: R28 11. Commitments and Contingencies (Tables) HTML 24K
42: R29 1. Organization, Liquidity and Summary of HTML 25K
Significant Accounting Policies (Details)
43: R30 1. Organization, Liquidity and Summary of HTML 76K
Significant Accounting Policies (Details
Narrative)
44: R31 2. Property and Equipment (Details) HTML 27K
45: R32 2. Property and Equipment (Details Narrative) HTML 21K
46: R33 3. Patents, Net (Details) HTML 29K
47: R34 3. Patents, Net (Details Narrative) HTML 24K
48: R35 4. Convertible Notes Payable (Details - HTML 24K
Convertible note December 2016 activity)
49: R36 4. Convertible Notes Payable (Details Narrative) HTML 27K
50: R37 5. Equity Transactions (Details - Warrant issued) HTML 29K
51: R38 5. Equity Transactions (Details - Warrant HTML 45K
activity)
52: R39 5. Equity Transactions (Details - Warrant HTML 32K
assumptions)
53: R40 5. Equity Transactions (Details - Warrants HTML 39K
outstanding and exercisable)
54: R41 5. Equity Transactions (Details - Options vested) HTML 33K
55: R42 5. Equity Transactions (Details - Option activity) HTML 45K
56: R43 5. Equity Transactions (Details - Options HTML 42K
exercisable)
57: R44 5. Equity Transactions (Details - Stockbased HTML 24K
Compensation)
58: R45 5. Equity Transactions (Details Narrative) HTML 176K
59: R46 6. Related Party Transactions (Details) HTML 25K
60: R47 6. Related Party Transactions (Details Narrative) HTML 20K
61: R48 7. Other Current Liabilities (Details) HTML 27K
62: R49 8. Income Taxes (Details - Deferred tax assets) HTML 37K
63: R50 8. Income Taxes (Details - Provision for income HTML 36K
taxes)
64: R51 8. Income Taxes (Details Narrative) HTML 27K
65: R52 9. Segments (Details) HTML 67K
66: R53 11. Commitments and Contingencies (Details - Rent) HTML 26K
67: R54 11. Commitments and Contingencies (Details HTML 33K
Narrative)
69: XML IDEA XML File -- Filing Summary XML 123K
68: EXCEL IDEA Workbook of Financial Reports XLSX 94K
8: EX-101.INS XBRL Instance -- aemd-20210331 XML 1.19M
10: EX-101.CAL XBRL Calculations -- aemd-20210331_cal XML 143K
11: EX-101.DEF XBRL Definitions -- aemd-20210331_def XML 445K
12: EX-101.LAB XBRL Labels -- aemd-20210331_lab XML 812K
13: EX-101.PRE XBRL Presentations -- aemd-20210331_pre XML 653K
9: EX-101.SCH XBRL Schema -- aemd-20210331 XSD 139K
70: ZIP XBRL Zipped Folder -- 0001683168-21-002707-xbrl Zip 129K
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Aethlon Medical, Inc. (the “Registrant”) on Form 10-K for the fiscal year ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof, I, James B. Frakes, Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Annual Report on Form 10-K fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and
2. The information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Aethlon Medical, Inc.
| Dated: June 24, 2021 | /s/ JAMES B. FRAKES |
| James B. Frakes | |
| Chief Financial Officer | |
| Aethlon Medical, Inc. |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Aethlon Medical, Inc. and will be retained by Aethlon Medical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/24/21 | 8-K | ||
| For Period end: | 3/31/21 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/29/22 Aethlon Medical Inc. 424B5 1:222K GlobalOne Filings Inc/FA 3/24/22 Aethlon Medical Inc. 424B5 1:226K GlobalOne Filings Inc/FA 9/30/21 Aethlon Medical Inc. S-3 3:215K GlobalOne Filings Inc/FA |